Latest news and upcoming events
Renowned Pioneers in Ophthalmology Join SparingVision’s Scientific Advisory Board
Development of lead asset SPVN06 to further benefit from high-level Clinical Advisory Board.
VarmX appoints Dr. Gerard Short as Chief Medical Officer
VarmX today announces the appointment of Dr. Gerard Short, MBBS, as Chief Medical Officer (CMO).
Minoryx presents topline results from Phase 2/3 “ADVANCE” study demonstrating significant clinical benefit of leriglitazone in adrenomyeloneuropathy (AMN)
Minoryx Therapeutics today announces that a lead investigator of the Minoryx Phase 2/3 ADVANCE clinical trial will present further results of the study at the 2021 Virtual Annual Meeting of the American Neurological Association.
Inbiomotion raises an oversubscribed financing round to launch its diagnostic product in breast cancer
IInbiomotion SL today announced that Alta Life Sciences has led a significantly oversubscribed investment round in the company.
Splice Bio appoints Jean-Philippe Combal as Chairman of the Board of Directors
Splice Bio announced today that it has appointed Jean-Philippe Combal as Chairman of its Board of Directors.
Hospital Vall d’Hebron Investigators Publish Early Data on Anaconda Biomed’s Mechanical Thrombectomy System for Ischemic Stroke
Initial single-center clinical study data supporting Anaconda Biomed’s Advanced Neurovascular Access™ (ANA) Catheter System for the treatment of ischemic stroke have been published
AM-Pharma Announces Enrollment and Financing of COVID-19 Cohort in Phase III REVIVAL Trial
AM-Pharma B.V. today announced that the first patients with COVID-19 infection and sepsis-associated acute kidney injury (SA-AKI) have been enrolled in the Company’s Phase III REVIVAL pivotal trial
CorWave Raises €35 Million in Series C Funding for Its Breakthrough Heart Pump; EIC Fund Joins as New Investor
CorWave raises 35 million euros to fund the next stages of its development, with the ambition to become a world-class medtech company serving heart failure patients.
Aura Biosciences Appoints David Johnson to Its Board of Directors
Aura Biosciences today announced the appointment of David Johnson to its Board of Directors.
International Consortium Awarded Eurostars Grant for the Development of First-in-class Treatment of Metastatic Cancer
ONA Therapeutics, Absolute Antibody and RIC – three leading European companies in the biotech landscape – have been awarded a Eurostars grant for a two-year project
Subscribe to our weekly newsletter for the latest
updates on life sciences investments.